A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease
Clinical trial NCT02974322 · WITHDRAWN
Trial details
- NCT number
- NCT02974322
- Sponsor
- Celgene
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-01
- Primary completion
- 2018-11-17
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.